A Phase I Dose-Finding Study Of Metformin In Combination With Concurrent Cisplatin And Radiation In Patients With Locally Advanced Head And Neck Squamous Cell Carcinoma.
Posted Date: Feb 7, 2018
- Investigator: Trisha Wise-Draper
- Specialties: Hematology/Oncology, Oncology, Cancer
- Type of Study: Drug
The purpose of this research study is to test the safety of adding metformin to treatment that you will already be getting for your cancer. You will be offered “standard of care” treatment whether you participate in this study or not. The standard of care treatment will be cisplatin once every 3 weeks for 3 treatments and radiation for 7 weeks. The risks and benefits of the standard of care treatment will be discussed by your regular doctor.
To Be Eligible To Participate, Patients Must Have Head And Neck Cancer That Requires Treatment With Cisplatin And Radiation.
Head & Neck, Ucci-Hn-14-01, Squamous Cell, Cancer, Null
For More Information:
Uc Cancer Institute